Fatar mu tana kaurin ta raguwa yayin da muke tsufa, kuma wani sabon binciken beraye ya nuna cewa wani sanannen sinadarin kari na iya rage wannan al'amari. Amma abin da ya sa ake jayayya shi ne babu wani shaida da ke nuna cewa yana aiki a mutane.
Masana daga Jami'ar Kiwon Lafiya ta Sapporo a Japan sun ba berayen da ke tsufa Resveratrol na tsawon makonni 32. Berayen da aka ba maganin sun kusan kauce wa raguwar kaurin epidermis da dermis da aka gani a cikin berayen da ba a ba da magani ba. Ga abin da binciken ya gano, abin da bai gani ba, da kuma menene hakan ke nufi idan kana tunanin siyan kwalban Resveratrol.
Babban Sakamako: Ba a Samu Ragin Kaurin Fata a Beraye ba
Binciken da Tamura da Kuno suka jagoranta an wallafa shi a Journal of Dermatology (2026;53(11):1650‑1659). An gwada ko Resveratrol, wanda aka san shi da ƙarfafa enzyme SIRT1, zai iya rage raguwar kaurin fata da ke alaka da shekaru.
Shekaru na sanya epidermis da dermis su yi kauri ƙasa, wanda ke haifar da bushewa, ƙasƙanci, da rauni a garkuwar fata. A cikin gwajin:
- Beraye masu shekaru 60 sun nuna epidermis da dermis masu kauri ƙasa idan aka kwatanta da beraye masu shekaru 20.
- An ba da Resveratrol a cikin abinci a 0.4 g a kowace kilogram na abinci, daga shekara 28 har zuwa makonni 32.
- Wannan magani ya rage raguwar kaurin a dukkan matakan fata.
Kalmar da ake amfani da ita ita ce reduced (an rage), ba a share ba. Marubutan sun ce Resveratrol ya rage raguwar da ke faruwa sakamakon tsufa.
Yadda Ya Ke Aiki: Alamu Uku
1. Ƙwayoyin fata sun dawo da yawaita
A epidermis, yawan ƙwayoyin Ki‑67‑positive (alama ga ƙwayoyin da ke haɓaka) ya ragu a berayen da suka tsufa. Resveratrol ya dawo da wannan adadi.
2. Ayyukan SIRT1 ya ƙaru, ba yawan SIRT1 ba
Resveratrol bai canza yawan ƙwayoyin SIRT1‑positive ba, amma ya rage yawan ƙwayoyin acetyl‑lysine‑positive, abin da marubuta suka fassara a matsayin ƙaruwar aikin SIRT1. SIRT1 yana ɗaukar NAD⁺ don yin deacetylase, wato cire ƙungiyoyin acetyl daga furotin. Ƙarancin acetylated targets na nuna cewa an yi wannan aiki sosai.
3. Enzayim ɗin da ke cin collagen sun tsaya shiru
A dermis, MMP‑9 da MMP‑13 su ne matrix metalloproteinases da ke karya extracellular matrix, ciki har da collagen. Immunopositivity na waɗannan enzayim din ya ƙaru a berayen da suka tsufa, amma ba a ga wannan ƙaruwa ba a berayen da suka samu Resveratrol.
Cikakken Bayani da Sauran Hujjoji
Matsayin phosphorylated SMAD2, alama da ke da alaka da siginar TGF‑β, ya ragu da shekaru. Resveratrol bai canza wannan ba. Don haka maganin ba ya gyara komai game da fatar da ke tsufa. Tasirin kariya ya bayyana ne ta hanyar rage senescence a epidermis da rage lalacewar collagen a dermis, ba tare da dawo da cikakkiyar siginar matasa ba.
Aikin Ƙwayoyin: Me Ya Sa SIRT1 Ya Mahimmanci
Ƙungiyar ta kuma gudanar da gwajin ƙwayoyin keratinocyte na ɗan adam (HaCaT). Lokacin da suka rage SIRT1 a cikin waɗannan ƙwayoyin, yawan p21 ya ƙaru, haka kuma aikin senescence‑associated β‑galactosidase ya ƙaru. Duka alamu ne na senescence. Wannan yana goyon bayan ra'ayin cewa SIRT1 na taimakawa wajen hana ƙwayoyin fata shiga yanayin senescence, amma wannan sakamakon na ƙwayoyin ne, ba na mutum ba.
NAD⁺ da Mahallin Sirtuin
SIRT1 na buƙatar NAD⁺ don aiki. Shi ya sa ake yawan tattaunawa tsakanin Resveratrol, NAD⁺ precursors, da kayayyakin “sirtuin activator”. Wannan binciken ya gwada Resveratrol kawai. Bai gwada NAD⁺ boosters ba, don haka ba zai iya cewa su ma za su haifar da irin wannan tasirin fata ba.
Abubuwan Da Za a Iya Amfani Da Su
Binciken beraye, ba gwajin mutum ba
Wannan binciken na dabbobi ne tare da ƙarin aikin ƙwayoyin keratinocyte. An auna kaurin fata da alamomin ƙwayoyin. Ba a gwada kuraje, ruwa, ko aikin garkuwa kai tsaye a mutane ba.
Mafi girman adadi ba ya sauyawa kai tsaye
Adadin da aka ba berayen shine 0.4 g na Resveratrol a kowace kilogram na abinci. Wannan yana nuni da ƙunshe a ciyawa, ba adadin mutum ba, kuma yanayin metabolism na beraye ya bambanta da namu. Takardar ba ta ƙayyade adadin da zai yi tasiri a mutane ba. Kayan Resveratrol a kasuwa yawanci suna zuwa a cikin kwaya 100‑500 mg, amma waɗannan adadi ba a tabbatar da su ba bisa ga wannan binciken don fata.
Matsalar bioavailability
Oral Resveratrol ba shi da kyau a sha sosai. An sha shi amma jiki na narkewa da sauri, don haka matakin jini na sinadarin mai aiki zai iya kasancewa ƙasa. Ko fata a cikin mutane za ta samu isasshen Resveratrol na buɗe tambaya. Wasu mutane suna sha tare da abinci mai mai, amma ba a kafa wani tsari na lokaci ba don samun sakamakon fata.
Oral vs. topical
Wannan binciken ya yi amfani da shan baki, ba a gwada mannewa ko serum ba, don haka ba ya ba da hujja cewa Resveratrol a cikin ƙwarya zai yi aiki iri ɗaya.
Waɗanda Zasu Iya Tunani, da Waɗanda Ya Kamata Su Guji
Mai yiwuwa a tattauna da likita: manyan manya masu sha'awar dabarun dogon lokaci na rage tsufar fata, waɗanda suka fahimci cewa hujjojin suna a matakin pre‑clinical kuma suna da ra'ayin gwaji.
Ya kamata su yi taka tsantsan ko su guje:
- Duk wanda ke ciki da ciki ko shayarwa
- Mutanen da ke ɗaukar magungunan rage jini ko wasu magunguna masu haɗari, domin kari na iya hulɗa da tsarin magunguna
- Mutanen da ke da cututtukan da ke da alaƙa da hormones
- Duk wanda ke tsammanin samun maganin kuraje da aka tabbatar da inganci
Mabambantan ka’idojin da aka tabbatar don rage tsufar fata, kamar amfani da sunscreen a kullum da guje wa shan taba, suna da hujjoji masu ƙarfi a mutane fiye da kowanne sirtuin activator.
Kammalawa
A cikin berayen da suka tsufa, shan Resveratrol na dogon lokaci ya rage raguwar kaurin fata, ya dawo da yawaitar ƙwayoyin epidermal, ya ƙara alamar aiki na SIRT1, kuma ya hana ƙaruwa MMP‑9 da MMP‑13 da ke alaka da shekaru. Aikin ƙwayoyin na goyon bayan rawar SIRT1 a hana senescence na keratinocyte. Amma adadin da zai yi tasiri a ɗan adam, hanyar isarwa, da fa'ida ba su da tabbaci.
Source: Tamura F, Nojima I, Kunimoto R, et al. SIRT1 Activator Resveratrol Attenuates Age‑Related Skin Thinning in Mice. J Dermatol. 2026;53(11):1650‑1659. DOI: https://doi.org/10.1111/1346-8138.70471. PubMed: https://pubmed.ncbi.nlm.nih.gov/42638272/